Time-dependent burden of reflux-related endoscopic pathology after sleeve gastrectomy: Clinical value of surveillance endoscopy in a 520-patient cohort

Figure 1 Study flow diagram. The exclusion criteria are shown in a separate box. The de novo Barrett’s esophagus cohort excluded patients with preoperative Barrett’s esophagus.

Figure 2 Preoperative vs postoperative reflux-related findings. GERD: Gastroesophageal reflux disease; PPI: Proton pump inhibitor; LA-B+: Los Angeles grade B or higher.

Figure 3 Strict clinically significant endoscopic pathology and treatment changes by follow-up duration.

Figure 4 De novo Barrett’s esophagus by follow-up duration using corrected eligible denominators: 3/138 (2. 2%), 14/195 (7.2%), and 17/169 (10.1%).

Figure 5 Forest plot of multivariable predictors of strict clinically significant postoperative endoscopic pathology after the removal of preoperative Barrett’s esophagus because of sparse data instability. The reference group for the follow-up duration was 24-36 months. GERD: Gastroesophageal reflux disease; BMI: Body mass index; LA-B+: Los Angeles grade B or higher.